Hypothesis: Sarcoidosis is a STAT1-mediated disease

Clinical Immunology

Volumn 132, Issue 2, 2009, Pages 174-183

  Rosenbaum, James T ^a,b   Pasadhika, Sirichai ^a   Crouser, Elliott D ^c   Choi, Dongseok ^a   Harrington, Christina A ^a   Lewis, Jinnell A ^a   Austin, Carrie R ^a   Diebel, Tessa N ^a   Vance, Emily E ^a   Braziel, Rita M ^a   Smith, Justine R ^a   Planck, Stephen R ^a,b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c OHIO STATE UNIVERSITY   (United States)

Author keywords

Gene expression profiling; Microarray analysis; Sarcoidosis; Uveitis

Indexed keywords

CHEMOKINE; INTERFERON; MESSENGER RNA; STAT1 PROTEIN;

ADULT; AGED; ARTICLE; BLOOD; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE EXPRESSION; GRANULOMA; HUMAN; HUMAN TISSUE; HYPERCALCEMIA; LUNG; LUNG LAVAGE; LYMPH NODE; MALE; MICROARRAY ANALYSIS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SARCOIDOSIS; TH1 CELL; UPREGULATION;

ADULT; AGED; DOWN-REGULATION; FEMALE; GENE EXPRESSION PROFILING; GENE REGULATORY NETWORKS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LUNG; LYMPH NODES; MALE; MIDDLE AGED; MODELS, GENETIC; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHOSPHOPROTEINS; RECEPTORS, INTERFERON; SARCOIDOSIS; STAT1 TRANSCRIPTION FACTOR; UP-REGULATION; YOUNG ADULT;

EID: 67649976622     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2009.04.010     Document Type: Article

References (62)

1. Culver D.A., Newman L.S., and Kavuru M.S. Gene-environment interactions in sarcoidosis: challenge and opportunity. Clin. Dermatol. 25 (2007) 267-275
2. Spagnolo P., and DuBois R.M. Genetics of sarcoidosis. Clin. Dermatol. 25 (2007) 242-249
3. Hans C.P., Weisenburger D.D., Greiner T.C., Gascoyne R.D., et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood 103 (2004) 275-282
4. Dai D.L., Wang Y., Liu M., Martinka M., and Li G. Bim expression is reduced in human cutaneous melanomas. Invest. Dermatol. 128 (2008) 403-407
5. Driouch K., Landemaine T., Sin S., Wang S., and Lidereau R. Gene arrays for diagnosis, prognosis, and treatment of breast cancer metastasis. Clin. Exp. Metastasis. 24 (2007) 575
6. Baechler E.C., Batliwalla F.M., Karypis G., Gaffney P.M., Ortmann W.A., Espe K.J., Shark K.B., Grande W.J., Hughes K.M., Kapur V., Gregersen P.K., and Behrens T.W. Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 2610-2615
7. Szodoray P., Alex P., Frank M.B., Turner M., Turner S., Knowlton N., Cadwell C., Dozomorov I., Tang Y., Wilson P.C., Jonsson R., and Centola M. A genome-scale assessment of peripheral blood B-cell molecular homeostasis in patients with rheumatoid arthritis. Rheumatology 45 (2006) 1466-1476
8. Mandel M., Gurevich M., Pauzner R., Kaminski N., and Achiron A. Autoimmunity gene expression portrait: specific signature that intersects or differentiates between multiple sclerosis and systemic lupus erythematosus. Clin. Exp. Immunol. 138 (2004) 164-170
9. Baechler E.C., Bauer J.W., Slattery C.A., Ortmann W.A., Espe K.J., Novitzke J., Ytterbert S.R., Gregersen P.K., Behrens T.W., and Reed A.M. An interferon signature in the peripheral blood of dermatomyositis patients is associated with disease activity. Mol. Med. 13 (2007) 59-68
10. Brierly M.M., and Fish E.N. Stats: multifaceted regulators of transcription. J. Interferon Cytokine Res. 25 (2005) 733-744
11. Sweiss N.J., Curran J., and Baughman R.P. Sarcoidosis, role of tumor necrosis factor inhibitors and other biologic agents, past, present, and future concepts. Clin. Dermatol. 25 (2007) 341-346
12. Winterbauer R.H., Belic N., and Moores K.D. Clinical interpretation of bilateral hilar adenopathy. Ann. Intern. med. 78 (1973) 65-71
13. A.T. Society. American Thoracic Society statement on sarcoidosis. Am. J. Respir. Crit. Care Med. 160 (1999) 736-755
14. Vartanian K., Slottke R., Johnstone T., Casale A., Planck S.R., Choi D., Smith J.R., Rosenbaum J.T., and Harrington C.A. Gene expression profiling of whole blood: comparison of target preparation methods for accurate and reproducible microarray analysis. BMC Genomics 10 (2009) 2
15. Team R.D.C. R: A Language and Environment for Statistical Computing R Foundation for Statistical Computing, Viena (2007)
16. Wu Z., Irizarry R.A., Gentleman R., et al. A model-based background for adjustment for oligonucleotide expression arrays. J. Am. Stat. Assoc. 99 (2004) 909-917
17. Li W., and Wong W.H. Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 31-36
18. Irizarry R.A., Hobbs B., Collin F., et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4 (2003) 249-264
19. Tusher V.G., Tibshirani R., and Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 5116-5121
20. Benjamini Y., and Hochbert Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. B 57 (1995) 289-300
21. Storey J. A direct approach to false discovery rates. J. R. Stat. Soc. B 64 (2002) 479-498
22. Wingender E., et al. TRANSFAC: an integrated system for gene expression regulation. Nucleic Acids Res. 28 (2000) 316-319
23. D. Choi, S.M. Sharma, S. Pasadhika, Z. Kang, C.A. Harrington, J.R. Smith, S.R. Planck, and J.T. Rosenbaum, Application of Biostatistics and Bioinformatics Tools to Identify Putative Transcription Factor-Gene Regulatory Network of Ankylosing Spondylitis and Sarcoidosis. Commun. Stat. - Theory and Methods (in press), doi:10.1080/03610920902898472.
24. Wright G.W., and Simon R.M. A random variance model for detection of differential gene expression in small microarray experiments. Bioinformatics 19 (2003) 2448-2455
25. E.D. Crouser, D.A. Culver, K.S. Knox, M.W. Julian, G. Shao, S. SAbraham, S. Liyanarachchi, J.E. Marcre, M.D. Wewers, M.A. Gavrilin, P. Ross, A. Abbas, and C. Eng, Gene expression profiling identifies MMP-12 and ADAMDEC1 as potential pathogenic mediators of pulmonary sarcoidosis. Am. J. Respir. Crit. Care Med. 179 (2009) 929-938.
26. Song Z., Marzilli L., Greenlee B.M., Chen E.S., Silver R.F., Askin F.B., Teirstein A.S., Zhang Y., Cotter R.J., and Moller D.R. Mycobacterial catalase-peroxidase is a tissue antigen and target of the adaptive immune response in systemic sarcoidosis. J. Exp. Med. 201 (2005) 755-767
27. Carlisle J., Evans W., Hajizadeh R., Nadaf M., Shepherd B., Ott R.D., Richter K., and Drake W. Multiple mycobacterium antigens induce interferon-gamma production from sarcoidosis peripheral blood mononuclear cells. Clin. Exp. Immunol. 150 (2007) 460-468
28. Chapgier A., Boisson-Dupuis S., Jouanguy E., Vogt G., Feinberg J., Prochnicka-Chalufour A., Casrouge A., Yang K., Soudais C., Fieschi C., Santos O.F., Bustamante J., Picard C., DeBeaucoudrey L., Emile J.F., Arkwright P.D., Schreiber R.D., Rolinck-Werninghaus C., Rosen-Wolff A., Magdorf K., Roesler J., and Casanova J.L. Novel STAT1 alleles in otherwise healthy patients with mycobacterial disease. PLoS Genet. 2 (2006) e131
29. Sugawara I., Yamada H., and Mizuno S. STAT1 knockout mice are highly susceptible to pulmonary mycobacterial infection. J. Exp. Med. 202 (2004) 41-50
30. Lan K.P., Wang C.J., Hsu J.D., Chen K.M., Lai S.C., and Lee H.H. Induced eosinophilia and proliferation in Angiostrongylus cantonensis-infected mouse brain are associated with the induction of JAK/STAT1, IAP/NF-?B and MEKK1/JNK signals. J. Helminthol. 78 (2004) 311-317
31. Antoniou K.M., Tzouvelekis A., Alexandrakis M.G., Tsiligianni I., Tzanakis N., Sfiridaki K., Rachiotis G., Bouros D., and Siafakas N.M. Upregulation of Th1 cytokine profile (IL-12, IL-18) in bronchoalveolar lavage fluid in patients with pulmonary sarcoidosis. J. Interferon Cytokine Res. 26 (2006) 400-405
32. Inui N., Chida K., Suda T., and Nakamura H. TH1/TH2 and TC1/TC2 profiles in peripheral blood and bronchoalveolar lavage fluid cells in pulmonary sarcoidosis. J. Allergy Clin. Immunol. 107 (2001) 337-344
33. Prasse A., Georges C.G., Biller H., Hamm H., Matthys H., Luttmann W., and Virchow J.C.J. Th1 cytokine pattern in sarcoidosis is expressed by bronchoalveolar CD4+ and CD8+ cells. Clin. Exp. Immunol. 122 (2000) 241-248
34. Overbergh L., Stoffels K., Waer M., Verstuyf A., Bouillon R., and Mathieu C. Immune regulation of 25-hydroxyvitamin d-1alpha-hydroxylase in human monocytic THP1 cells: mechanisms of interferon-gamma-mediated induction. J. Clin. Endocrinol. Metab. 91 (2006) 3566-3574
35. Takeuchi M., Oh-I K., Suzuki J., Hattori T., Takeuchi A., Okunuki Y., Usui Y., and Usui M. Elevated serum levels of CXCL9/monokine induced by interferon-gamma and CXCL10/interferon-gamma-inducible protein-10 in ocular sarcoidosis. Invest. Ophthalmol. Vis. Sci. 47 (2006) 1063-1068
36. Schischmanoff P.O., Naccache J.M., Carrere A., Richardson S., Kambouchner M., Raphael M., Valeyre D., and Fagard R. Progressive pulmonary sarcoidosis is associated with over-expression of TYK2 and p21Waf1/Cip1. Sarcoidosis Vasc. Diffuse Lung Dis. 23 (2006) 101-107
37. Alazemi S., and Campos M.A. Interferon-induced sarcoidosis. Int. J. Clin. Pract. 60 (2006) 201-211
38. Fiel M.I., Shukla D., Saraf N., Xu R., and Shciano T.D. Development of hepatic granulomas in patients receiving pegylated interferon therapy for recurrent hepatitis C virus post liver transplantation. Transpl. Infect. Dis. 10 (2008) 184-189
39. Goldberg H.J., Fiedler D., Webb A., Jagirdar J., Hoyumpa A.M., and Peters J. Sarcoidosis after treatment with interferon-alpha: a case series and review of the literature. Respir. Med. 100 (2006) 2063-2068
40. Carter S.L., Muller M., Manders P.M., and Campbell L. Induction of the genes for Cxcl9 and Cxcl10 is dependent on IFN-gamma but shows differential cellular expression in experimental autoimmune encephalomyelitis and by astrocytes and microglia in vitro. Glia 55 (2007) 1728-1739
41. Fuller C.L., Flynn J.L., and Reinhart T.A. In situ study of abundant expression of proinflammatory chemokines and cytokines in pulmonary granulomas that develop in cynomolgus macaques experimentally infected with Mycobacterium tuberculosis. Infect. Immun. 71 (2003) 7023-7034
42. Mee J.B., Johnson C.M., Morar N., Burslem F., and Groves R.W. The psoriatic transcriptome closely resembles that induced by interleukin-1 in cultured keratinocytes: dominance of innate immune responses in psoriasis. Am. J. Path. 171 (2007) 32-42
43. Wenzel J., Peters B., Zahn S., Birth M., Hofmann K., Kusters D., Tomiuk S., Baron J.M., Merk H.F., Mauch C., Krieg T., Bieber T., Tuting T., and Bosio A. Gene expression profiling of lichen planus reflects CXCL9+-mediated inflammation and distinguishes this disease from atopic dermatitis and psoriasis. J. Invest. Dermatol. 128 (2008) 67-78
44. Egesten A., Eliasson M., Olin A.I., Erjefait J.S., Bjartell A., Sangfelt P., and Carlson M. The proinflammatory CXC-chemokines GRO-alpha/CXCL1 and MIG/CXCL9 are concomitantly expressed in ulcerative colitis and decrease during treatment with topical corticosteroids. Int. J. Colorectal Dis. 22 (2007) 1421-1427
45. Shin J.J., Glickstein L.J., and Steere A.C. High levels of inflammatory chemokines and cytokines in joint fluid and synovial tissue throughout the course of antibiotic-refractory lyme arthritis. Arthritis. Rheum. 56 (2007) 1325-1335
46. Frisullo G., Angelucci F., Cagguila M., Nociti V., Iorio R., Patanella A.K., Sancricca C., Mirabella M., Tonali P.A., and Batocchi A.P. pSTAT1, pSTAT3, and T-bet expression in peripheral blood mononuclear cells from relapsing-remitting multiple sclerosis patients correlates with disease activity. J. Neurosci. Res. 84 (2006) 1027-1036
47. Johnson L.M., and Scott P. STAT1 expression in dendritic cells, but not T cells, is required for immunity to Leishmania major. J. Immunol. 178 (2007) 7259-7266
48. Anathbandhu C., Yang B., Gendelman H.E., Persidsky Y., and Kanmogne G.D. STAT1 signaling modulates HIV-1-induced inflammatory responses and leukocyte transmigration across the blood-brain barrier. Blood 111 (2008) 2060-2072
49. Bermudez L., Petrofsky M., and Shelton K. Epidermal growth factor-binding protein in mycobacterium avium and mycobacterium tuberculosis: a possible role in the mechanism of infection. Infect. Immun. 64 (1996) 2917-2922
50. van der Fits L., van der Wei L.I., Laman J.D., Prens E.P., and Verschuren M.C. In psoriasis lesional skin the type I interferon signaling pathway is activated, whereas interferon-alpha sensitivity is unaltered. J. Invest. Dermatol. 122 (2004) 51-60
51. Kasperkovitz P.V., Verbeet N.L., Smeets T.J., van Rietschoten J.G., Kraan M.C., and van der Pouw Kraan T.C. Activation of the STAT1 pathway in rheumatoid arthritis. Ann. Rheum. Dis. 63 (2004) 233-239
52. Remmers E.F., Plenge R.M., Lee A.T., Graham R.R., et al. STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus. N. Engl. J. Med. 357 (2007) 977-986
53. Land K.J., Moll J.S., Kaplan M.H., and Seetharamaiah G.S. Signal transducer and activator of transcription (Stat)-6-dependent, but not Stat4-dependent, immunity is required for the development of autoimmunity in Graves' hyperthyroidism. Endocrinology 145 (2004) 3724-3730
54. Harton J.A., and Ting J.P. Class II transactivator: mastering the art of major histocompatibility complex expression. Mol. Cell. Biol. 20 (2000) 6185-6194
55. Harada H., et al. Absence of the type I IFN system in EC cells: transcriptional activator (IRF-1) and repressor (IRF-2) genes are developmentally regulated. Cell 63 (1990) 303-312
56. Otani A., et al. A fragment of human TrpRS as a potent antagonist of ocular angiogenesis. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 178-183
57. Van Kaer L., et al. Altered peptidase and viral-specific T cell response in LMP2 mutant mice. Immunity 1 (1994) 533-541
58. Pearse R.N., Feinman R., and Ravetch J.V. Characterization of the promoter of the human gene encoding the high-affinity IgG receptor: transcriptional induction by gamma-interferon is mediated through common DNA response elements. Proc. Natl. Acad. Sci. U. S. A. 88 (1991) 11305-11309
59. Amson R., et al. The human protooncogene product p33pim is expressed during fetal hematopoiesis and in diverse leukemias. Proc. Natl. Acad. Sci. U. S. A. 86 (1989) 8857-8861
60. Tsujimoto Y., et al. Molecular cloning of the chromosomal breakpoint of B-cell lymphomas and leukemias with the t(11;14) chromosome translocation. Science 224 (1984) 1403-1406
61. Rosenberg C.L., et al. Rearrangement and overexpression of D11S287E, a candidate oncogene on chromosome 11q13 in benign parathyroid tumors. Oncogene 6 (1991) 449-453
62. Kong S., et al. Cyclin D1 polymorphism and increased risk of colorectal cancer at young age. J. Natl. Cancer Inst. 93 (2001) 1106-1108